Model for Predicting Risk of Postpartum Purulent-Inflammatory Complications after Cesarean Section: Cohort Retrospective Study

Background. Relevance of the study is related to the lack of a unified strategy for determining the risk of infectious complications of puerperium. Currently, the specialists use the collected data from studies documenting the main factors of infection in a population or cohorts of postpartum women. However, accuracy of these factors is not established and prognosis could not be personalized. The paper analyzes significant risk factors for the infectious complications associated with cesarean section (C-Section) and develops a model for their prognosis and an individual assessment of the risk of postpartum infection in order to take timely preventive measures.

Objective. To identify predictors of postpartum purulent-inflammatory complications after cesarean section, to evaluate their predictive value, and to develop a statistical model for determining the risk of their occurrence.

Methods. The cohort retrospective study (January 2019 to January 2022) was conducted in four obstetric health facilities of Krasnodar and was focused on analysis of medical records. Anamnestic, clinical and laboratory data of all women after cesarean section delivery were collected. Model: a patient diagnosed with any infection associated with cesarean section within 42 days after delivery — postoperative suture infection, endometritis, peritonitis, thrombophlebitis, sepsis. Infections were grouped to carry out a single risk assessment with an internal validation test and to develop a multifactor logistic regression model. All analyses were conducted using version R 3.2.3 (SPSS Inc., Chicago, IL) and Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD).

Results. Infection associated with cesarean section occurred in 2.50% of women (n = 548; 95% CI 2.6–3.5), suture disruption — in 0.59% (n = 129; 95%, CI 0.41–0.81), endometritis — 1.46% (n = 321; 95%, CI 1.15–1.94), peritonitis — 0.16% (n = 35; 95%, CI 0.11–0.20), thrombophlebitis 0.04% (n = 9; 95%, CI 0.01–0.05), sepsis 0.25% (n = 54; 95%, CI 0.15–0.35). The authors have identified 14 major variables with a high prognostic risk for the development of infectious complications of puerperium. The model differentiated women with and without purulent inflammatory complications of puerperium by internal validation (concordance index = 0.712, 95%, CI 0.672–0.755).

Conclusion. The developed model can be used to accurately predict the risk of infectious complications after abdominal delivery and to identify high-risk patients. It ensures a differentiated approach with a possibility to expand studies and strengthen antibiotic therapy, which promotes reduction of surgical site puerperal infection.

1. Zhilinkova N.G. Modern ideas about puerperal infections due to antibacterial resi the stent and the end of the antibiotic era. Obstetrics and Gynecology: News, Opinions, Training. 2019; 7(3): 70–75 (In Russ.). DOI: 10.24411/2303-96982019-13010.

2. Shi M., Chen L., Ma X., Wu B. The risk factors and nursing countermeasures of sepsis after cesarean section: a retrospective analysis. BMC Pregnancy Childbirth. 2022; 22(1): 696. DOI: 10.1186/s12884-02204982-8

3. Korobkov N.A. Structure of nosocomial infectious and infl ammatory complications after abdominal delivery. Avicenna Bulletin. 2018; 20(1): 20–25 (In Russ.). DOI: 10.25005/2074-0581-2018-20-1-20-25

4. Galustyan M.V., Kutsenko I.I., Borovikov I.O. Features of abdominal delivery in obstetric institutions of level III. Kuban Scientifi c Medical Bulletin. 2020; 27(2): 49–58 (In Russ.). DOI: 10.25207/16086228-2020-27-2-49-58

5. Axelsson D., Brynhildsen J., Blomberg M. Postpartum infection in relation to maternal characteristics, obstetric interventions and complications. J. Perinat. Med. 2018; 46(3): 271–278. DOI: 10.1515/jpm2016-0389. PMID: 28672754.

6. Mitichkin A.E., Dobrokhotova Yu.E., Ivannikov N.Yu., Dimitrova V.I., Slyusareva O.A., Khlynova S.A., Lyubeshkina V.A., Taalaybekova A.T. Prophylaxis of рurulent-septic diseases of postpartum period for high-risk puerperas. Medical Council. 2020; 3: 164–169 (In Russ.). DOI: 10.21518/2079-701X-2020-3-164-169.

7. Igwemadu G.T., Eleje G.U., Eno E.E., Akunaeziri U.A., Afolabi F.A., Alao A.I., Ochima O. Single-dose versus multiple-dose antibiotics prophylaxis for preventing caesarean section postpartum infections: A randomized controlled trial. Womens Health (Lond). 2022; 18: 17455057221101071. DOI: 10.1177/17455057221101071

8. Faure K., Dessein R., Vanderstichele S., Subtil D. Endométrites du postpartum. RPC infections génitales hautes CNGOF et SPILF [Postpartum endometritis: CNGOF and SPILF Pelvic Infl ammatory Diseases Guidelines]. Gynecol. Obstet. Fertil. Senol. 2019; 47(5): 442–450. French. DOI: 10.1016/j.gofs.2019.03.013

9. Witter F.R., Lawson P., Ferrell J. Decreasing cesarean section surgical site infection: an ongoing comprehensive quality improvement program. Am. J. Infect. Control. 2014; 42(4): 429–431. DOI: 10.1016/j.ajic.2013.12.004

10. Chechneva M.A., Titchenko Iu.P., Rebrova T.V., Biriukova N.V., Matveev M.O. New approaches to the early diagnosis of postpartum endometritis. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20(1): 68–72 (In Russ.).DOI: 10.17116/rosakush20202001168

11. Hsu C.D., Cohn I., Caban R. Reduction and sustainability of cesarean section surgical site infection: An evidence-based, innovative, and multidisciplinary quality improvement intervention bundle program. Am. J. Infect. Control. 2016; 44(11): 1315–1320. DOI: 10.1016/j.ajic.2016.04.217

12. Knight M., Chiocchia V., Partlett C., Rivero-Arias O., Hua X., Hinshaw K., Tuffnell D., Linsell L., Juszczak E.; ANODE collaborative group. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial. Lancet. 2019; 393(10189): 2395–2403. DOI: 10.1016/S01406736(19)30773-1

13. Vallejo M.C., Attaallah A.F., Shapiro R.E., Elzamzamy O.M., Mueller M.G., Eller W.S. Independent risk factors for surgical site infection after cesarean delivery in a rural tertiary care medical center. J. Anesth. 2017; 31(1): 120–126. DOI: 10.1007/s00540-016-2266-2

14. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Plante L.A., Pacheco L.D., Louis J.M. SMFM Consult Series #47: Sepsis during pregnancy and the puerperium. Am. J. Obstet. Gynecol. 2019; 220(4): B2–B10. DOI: 10.1016/j.ajog.2019.01.216

15. Moulton L.J., Munoz J.L., Lachiewicz M., Liu X., Goje O. Surgical site infection after cesarean delivery: incidence and risk factors at a US academic institution. J. Matern. Fetal. Neonatal. Med. 2018; 31(14): 1873–1880. DOI: 10.1080/14767058.2017.1330882

16. Gomaa K., Abdelraheim A.R., El Gelany S., Khalifa E.M., Yousef A.M., Hassan H. Incidence, risk factors and management of post cesarean section surgical site infection (SSI) in a tertiary hospital in Egypt: a fi ve-year retrospective study. BMC Pregnancy Childbirth. 2021; 21(1): 634. DOI: 10.1186/s12884-021-04054-3

17. Saeed K.B., Corcoran P., O’Riordan M., Greene R.A. Risk factors for surgical site infection after cesarean delivery: A case-control study. Am. J. Infect. Control. 2019; 47(2): 164–169. DOI: 10.1016/j.ajic.2018.07.023

18. He X., Li D., Sun T., Dai Q., Hu M., Zhu Z., Sun X., Zhou J. Risk factors for surgical site infection after cesarean delivery in a rural area in China: A case-controlled study. Ann. Med. Surg. (Lond). 2021; 72: 103110. DOI: 10.1016/j.amsu.2021.103110

19. Moulton L.J., Munoz J.L., Lachiewicz M., Liu X., Goje O. Surgical site infection after cesarean delivery: incidence and risk factors at a US academic institution. J. Matern. Fetal. Neonatal. Med. 2018; 31(14): 1873–1880. DOI: 10.1080/14767058.2017.1330882

20. Riley M.M., Suda D., Tabsh K., Flood A., Pegues D.A. Reduction of surgical site infections in low transverse cesarean section at a university hospital. Am. J. Infect. Control. 2012; 40(9): 820–825. DOI: 10.1016/j.ajic.2011.12.011

21. Harris P.A., Taylor R., Thielke R., Payne J., Gonzalez N., Conde J.G. Research electronic data capture (REDCap) — a metadata-driven methodology and workfl ow process for providing translational research informatics support. J. Biomed. Inform. 2009; 42(2): 377–381. DOI: 10.1016/j.jbi.2008.08.010

22. Moulton L.J., Eric Jelovsek J., Lachiewicz M., Chagin K., Goje O. A model to predict risk of postpartum infection after Caesarean delivery. J. Matern. Fetal. Neonatal. Med. 2018; 31(18): 2409–2417. DOI: 10.1080/14767058.2017.1344632

23. Moulton L.J., Lachiewicz M., Liu X., Goje O. Endomyometritis after cesarean delivery in the era of antibiotic prophylaxis: incidence and risk factors. J. Matern. Fetal. Neonatal. Med. 2018; 31(9): 1214–1219. DOI: 10.1080/14767058.2017.1312330

24. Berríos-Torres S.I., Umscheid C.A., Bratzler D.W., Leas B., Stone E.C., Kelz R.R., Reinke C.E., Morgan S., Solomkin J.S., Mazuski J.E., Dellinger E.P., Itani K.M.F., Berbari E.F., Segreti J., Parvizi J., Blanchard J., Allen G., Kluytmans J.A.J.W., Donlan R., Schecter W.P.; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017; 152(8): 784–791. DOI: 10.1001/jamasurg.2017.0904

25. Shea S.K., Soper D.E. Prevention of Cesarean Delivery Surgical Site Infections. Obstet. Gynecol. Surv. 2019; 74(2): 99–110. DOI: 10.1097/OGX.0000000000000645

26. Axelsson D., Blomberg M. Maternal obesity, obstetric interventions and post-partum anaemia increase the risk of post-partum sepsis: a population-based cohort study based on Swedish medical health registers. Infect. Dis. (Lond). 2017; 49(10): 765–771. DOI: 10.1080/23744235.2017.1341055

27. Tanaka H., Katsuragi S., Hasegawa J., Tanaka K., Osato K., Nakata M., Murakoshi T., Sekizawa A., Kanayama N., Ishiwata I., Ikeda T. The most common causative bacteria in maternal sepsis-related deaths in Japan were group A Streptococcus: A nationwide survey. J. Infect. Chemother. 2019; 25(1): 41–44. DOI: 10.1016/j.jiac.2018.10.004

28. Blumenfeld Y.J., El-Sayed Y.Y., Lyell D.J., Nelson L.M., Butwick A.J. Risk Factors for Prolonged Postpartum Length of Stay Following Cesarean Delivery. Am. J. Perinatol. 2015; 32(9): 825–832. DOI: 10.1055/s-0034-1543953

29. Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstet. Gynecol. 2018; 132(3): e103–e119. DOI: 10.1097/AOG.0000000000002833

30. Olenev A.S., Konoplyannikov A.G., Vuchenovich Yu.D., Ziyadinov A.A., Novikova V.A., Radzinsky V.E. Septic Complications in Obstetrics: the Point of No Return. Evaluation and Prognosis. Doctor. Ru. 2020; 19(6): 7–14 (In Russ.). DOI: 10.31550/1727-2378-2020-19-67-14

31. Helmreich J.E. Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis (2nd Edition). Journal of Statistical Software 70 (Book Review 2). DOI:10.18637/jss.v070.b02

32. Cook N.R. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin. Chem. 2008; 54(1): 17–23. DOI: 10.1373/clinchem.2007.096529

33. Rufi bach K. Use of Brier score to assess binary predictions. J. Clin. Epidemiol. 2010; 63(8): 938–939; author reply 939. DOI: 10.1016/j.jclinepi.2009.11.009

34. Van Calster B., Vickers A.J. Calibration of risk prediction models: impact on decision-analytic performance. Med. Decis. Making. 2015; 35(2): 162–169. DOI: 10.1177/0272989X14547233

35. Berríos-Torres S.I., Umscheid C.A., Bratzler D.W., Leas B., Stone E.C., Kelz R.R., Reinke C.E., Morgan S., Solomkin J.S., Mazuski J.E., Dellinger E.P., Itani K.M.F., Berbari E.F., Segreti J., Parvizi J., Blanchard J., Allen G., Kluytmans J.A.J.W., Donlan R., Schecter W.P.; Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017; 152(8): 784–791. DOI: 10.1001/jamasurg.2017.0904

36. Collins G.S., Reitsma J.B., Altman D.G., Moons K.G. Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. J. Clin. Epidemiol. 2015; 68(2): 134–143. DOI: 10.1016/j.jclinepi.2014.11.010

37. Sandall J., Tribe R.M., Avery L., Mola G., Visser G.H., Homer C.S., Gibbons D., Kelly N.M., Kennedy H.P., Kidanto H., Taylor P., Temmerman M. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018; 392(10155): 1349– 1357. DOI: 10.1016/S0140-6736(18)31930-5

38. Gan R.X., Li Y., Song J., Wen Q., Lu G.X., Lin G., Gong F. Pregnancy Outcomes of Different Endometrial Preparation in Patients with a History of Cesarean Section. Front. Endocrinol. (Lausanne). 2022; 13: 813791. DOI: 10.3389/fendo.2022.813791

39. Veres I.A. Analysis of the clinical manifestations of postpartum subinvolution of the uterus as a pre-stage of hypotonic postpartum endometritis. Russian Bulletin of Obstetrician-Gynecologist. 2020; 20(5): 84–90 (In Russ.). DOI: 10.17116/rosakush20202005184